Viewing Study NCT00460161



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00460161
Status: SUSPENDED
Last Update Posted: 2009-02-18
First Post: 2007-04-12

Brief Title: Acupuncture for Phantom Limb Pain
Sponsor: Shaare Zedek Medical Center
Organization: Shaare Zedek Medical Center

Study Overview

Official Title: Acupuncture for Phantom Limb Pain A Randomized Double-Blind PlaceboSham - Controlled Study
Status: SUSPENDED
Status Verified Date: 2008-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Lack of patients
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Phantom pain is a common complication following limb amputation and is thought to result from a system of pathophysiological mechanisms - peripheral spinal central and psychological Treatment is primarily medical using antidepressant and anticonvulsant medications At present there is no evidence-based approach for the management of phantom limb pain PLP Acupuncture is an ancient Chinese treatment during which thin needles diameter 020-030mm are inserted into various points on the skin Studies of this treatment have found significant benefit in a number of conditions with chronic pain

We propose a randomized double-blind placebosham -controlled study to evaluate whether acupuncture is an effective and safe modality for preventing and reducing PLP in patients following lower limb amputation Patients requiring lower limb amputation above-ankle will be randomized into two groups for real or placebosham acupuncture treatment Both groups will be treated twice-weekly with a standardized as opposed to individualized acupuncture treatment protocol using either true or placebo needles at sham acupuncture points for a period of four weeks eight treatments

The primary outcome to be evaluated will be PLP at 4 weeks using a site-specific numerical rating pain scale ss-NRS Secondary outcome measures to be evaluated are stump pain ss-NRS analgesic use Tramadol 100mg Tablet and depressive symptoms using the Beck Depression Score Blinding of the participants will be evaluated using a Validation of Blinding Questionnaire at the end of the treatment period
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None